Bokf Na Sells 3,887 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

BOKF NA cut its position in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 42.4% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 5,279 shares of the biotechnology company's stock after selling 3,887 shares during the quarter. BOKF NA's holdings in Axon Enterprise were worth $3,009,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in AXON. Vanguard Group Inc. raised its stake in Axon Enterprise by 3.4% during the fourth quarter. Vanguard Group Inc. now owns 8,446,437 shares of the biotechnology company's stock worth $5,019,886,000 after acquiring an additional 275,959 shares in the last quarter. Geode Capital Management LLC increased its position in Axon Enterprise by 3.7% during the 4th quarter. Geode Capital Management LLC now owns 1,847,925 shares of the biotechnology company's stock worth $1,095,542,000 after purchasing an additional 65,097 shares in the last quarter. Capital World Investors lifted its stake in Axon Enterprise by 86.4% in the 4th quarter. Capital World Investors now owns 1,815,765 shares of the biotechnology company's stock valued at $1,079,145,000 after purchasing an additional 841,772 shares during the last quarter. Alliancebernstein L.P. lifted its stake in Axon Enterprise by 273.8% in the 4th quarter. Alliancebernstein L.P. now owns 1,109,045 shares of the biotechnology company's stock valued at $659,128,000 after purchasing an additional 812,337 shares during the last quarter. Finally, Norges Bank bought a new stake in shares of Axon Enterprise during the fourth quarter worth $482,081,000. Institutional investors own 79.08% of the company's stock.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the company. Craig Hallum cut Axon Enterprise from a "buy" rating to a "cautious" rating in a research note on Monday, March 10th. Northcoast Research downgraded Axon Enterprise from a "buy" rating to a "neutral" rating in a research report on Wednesday, February 19th. The Goldman Sachs Group boosted their price target on Axon Enterprise from $500.00 to $700.00 and gave the stock a "buy" rating in a report on Monday, January 27th. Needham & Company LLC raised their price objective on shares of Axon Enterprise from $600.00 to $750.00 and gave the company a "buy" rating in a report on Thursday. Finally, JMP Securities reissued an "outperform" rating on shares of Axon Enterprise in a report on Tuesday, February 4th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and ten have issued a buy rating to the stock. Based on data from MarketBeat.com, Axon Enterprise presently has a consensus rating of "Moderate Buy" and a consensus price target of $640.91.

Insider Activity

In other Axon Enterprise news, CEO Patrick W. Smith sold 10,000 shares of Axon Enterprise stock in a transaction on Monday, April 21st. The shares were sold at an average price of $540.99, for a total value of $5,409,900.00. Following the completion of the sale, the chief executive officer now directly owns 3,063,982 shares of the company's stock, valued at approximately $1,657,583,622.18. The trade was a 0.33 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Jeri Williams sold 307 shares of the company's stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $552.72, for a total transaction of $169,685.04. Following the transaction, the director now owns 1,627 shares in the company, valued at $899,275.44. This represents a 15.87 % decrease in their position. The disclosure for this sale can be found here. 4.40% of the stock is currently owned by company insiders.

Axon Enterprise Trading Down 0.3 %

AXON stock traded down $2.24 during midday trading on Friday, hitting $684.59. The stock had a trading volume of 642,401 shares, compared to its average volume of 764,683. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The firm has a market cap of $53.29 billion, a P/E ratio of 176.90, a price-to-earnings-growth ratio of 5.17 and a beta of 1.24. The business has a fifty day moving average price of $564.50 and a two-hundred day moving average price of $584.84. Axon Enterprise, Inc. has a 1-year low of $273.52 and a 1-year high of $715.99.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.34 by $0.07. The company had revenue of $603.63 million for the quarter, compared to the consensus estimate of $585.67 million. Axon Enterprise had a return on equity of 7.50% and a net margin of 15.37%. The firm's revenue was up 31.3% compared to the same quarter last year. During the same period in the previous year, the business earned $1.15 EPS. On average, sell-side analysts predict that Axon Enterprise, Inc. will post 5.8 earnings per share for the current fiscal year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.